MC1R-targeted alpha-particle monotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MC1R-targeted alpha-particle monotherapy, covering 2026-03-11 to 2026-03-11. Get the full timeline:
Most recent: Clinical Trial Update: MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma [Phase 1, Phase 2]